Literature DB >> 18834626

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.

Abbas Dehghan1, Anna Köttgen, Qiong Yang, Shih-Jen Hwang, Wh Linda Kao, Fernando Rivadeneira, Eric Boerwinkle, Daniel Levy, Albert Hofman, Brad C Astor, Emelia J Benjamin, Cornelia M van Duijn, Jacqueline C Witteman, Josef Coresh, Caroline S Fox.   

Abstract

BACKGROUND: Hyperuricaemia, a highly heritable trait, is a key risk factor for gout. We aimed to identify novel genes associated with serum uric acid concentration and gout.
METHODS: Genome-wide association studies were done for serum uric acid in 7699 participants in the Framingham cohort and in 4148 participants in the Rotterdam cohort. Genome-wide significant single nucleotide polymorphisms (SNPs) were replicated in white (n=11 024) and black (n=3843) individuals who took part in the study of Atherosclerosis Risk in Communities (ARIC). The SNPs that reached genome-wide significant association with uric acid in either the Framingham cohort (p<5.0 x 10(-8)) or the Rotterdam cohort (p<1.0 x 10(-7)) were evaluated with gout. The results obtained in white participants were combined using meta-analysis.
FINDINGS: Three loci in the Framingham cohort and two in the Rotterdam cohort showed genome-wide association with uric acid. Top SNPs in each locus were: missense rs16890979 in SLC2A9 (p=7.0 x 10(-168) and 2.9 x 10(-18) for white and black participants, respectively); missense rs2231142 in ABCG2 (p=2.5 x 10(-60) and 9.8 x 10(-4)), and rs1165205 in SLC17A3 (p=3.3 x 10(-26) and 0.33). All SNPs were direction-consistent with gout in white participants: rs16890979 (OR 0.59 per T allele, 95% CI 0.52-0.68, p=7.0 x 10(-14)), rs2231142 (1.74, 1.51-1.99, p=3.3 x 10(-15)), and rs1165205 (0.85, 0.77-0.94, p=0.002). In black participants of the ARIC study, rs2231142 was direction-consistent with gout (1.71, 1.06-2.77, p=0.028). An additive genetic risk score of high-risk alleles at the three loci showed graded associations with uric acid (272-351 mumol/L in the Framingham cohort, 269-386 mumol/L in the Rotterdam cohort, and 303-426 mumol/L in white participants of the ARIC study) and gout (frequency 2-13% in the Framingham cohort, 2-8% in the Rotterdam cohort, and 1-18% in white participants in the ARIC study).
INTERPRETATION: We identified three genetic loci associated with uric acid concentration and gout. A score based on genes with a putative role in renal urate handling showed a substantial risk for gout.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834626      PMCID: PMC2803340          DOI: 10.1016/S0140-6736(08)61343-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information.

Authors:  D Rabinowitz; N Laird
Journal:  Hum Hered       Date:  2000 Jul-Aug       Impact factor: 0.444

2.  Implementing a unified approach to family-based tests of association.

Authors:  N M Laird; S Horvath; X Xu
Journal:  Genet Epidemiol       Date:  2000       Impact factor: 2.135

3.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

4.  The Framingham Offspring Study. Design and preliminary data.

Authors:  M Feinleib; W B Kannel; R J Garrison; P M McNamara; W P Castelli
Journal:  Prev Med       Date:  1975-12       Impact factor: 4.018

Review 5.  ATP-binding cassette, subfamily G (ABCG family).

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  Pflugers Arch       Date:  2006-09-16       Impact factor: 3.657

6.  p-aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1.

Authors:  H Uchino; I Tamai; K Yamashita; Y Minemoto; Y Sai; H Yabuuchi; K i Miyamoto; E Takeda; A Tsuji
Journal:  Biochem Biophys Res Commun       Date:  2000-04-02       Impact factor: 3.575

7.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination.

Authors:  Greta Lee Splansky; Diane Corey; Qiong Yang; Larry D Atwood; L Adrienne Cupples; Emelia J Benjamin; Ralph B D'Agostino; Caroline S Fox; Martin G Larson; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Philip A Wolf; Daniel Levy
Journal:  Am J Epidemiol       Date:  2007-03-19       Impact factor: 4.897

Review 8.  The changing epidemiology of gout.

Authors:  Edward Roddy; Weiya Zhang; Michael Doherty
Journal:  Nat Clin Pract Rheumatol       Date:  2007-08

9.  Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution.

Authors:  Kazumasa Takenaka; Jessica A Morgan; George L Scheffer; Masashi Adachi; Clinton F Stewart; Daxi Sun; Markos Leggas; Karin F K Ejendal; Christine A Hrycyna; John D Schuetz
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  Identification of a new member of type I Na/phosphate co-transporter in the rat kidney.

Authors:  Kenichi Ishibashi; Toshiyuki Matsuzaki; Kuniaki Takata; Masashi Imai
Journal:  Nephron Physiol       Date:  2003
View more
  287 in total

1.  Effects of SLC2A9 variants on uric acid levels in a Korean population.

Authors:  Jae Woong Sull; Eun Jung Park; Myoungsook Lee; Sun Ha Jee
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

2.  Association between gout and polymorphisms in GCKR in male Han Chinese.

Authors:  Jing Wang; Shiguo Liu; Binbin Wang; Zhimin Miao; Lin Han; Nan Chu; Kun Zhang; Dongmei Meng; Changgui Li; Xu Ma
Journal:  Hum Genet       Date:  2012-03-07       Impact factor: 4.132

3.  Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.

Authors:  Brandon L Pierce; Habibul Ahsan; Tyler J Vanderweele
Journal:  Int J Epidemiol       Date:  2010-09-02       Impact factor: 7.196

Review 4.  Gout, hyperuricemia, and Parkinson's disease: a protective effect?

Authors:  Alvaro Alonso; Kelly A Sovell
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

5.  Genome-wide association studies and large-scale collaborations in epidemiology.

Authors:  Bruce M Psaty; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-07-11       Impact factor: 8.082

6.  Increased power of mixed models facilitates association mapping of 10 loci for metabolic traits in an isolated population.

Authors:  Eimear E Kenny; Minseung Kim; Alexander Gusev; Jennifer K Lowe; Jacqueline Salit; J Gustav Smith; Sirisha Kovvali; Hyun Min Kang; Christopher Newton-Cheh; Mark J Daly; Markus Stoffel; David M Altshuler; Jeffrey M Friedman; Eleazar Eskin; Jan L Breslow; Itsik Pe'er
Journal:  Hum Mol Genet       Date:  2010-11-30       Impact factor: 6.150

7.  Orthopaedic case of the month: medial knee pain in a 69-year-old man.

Authors:  Rej S Bhumbra; Monica Khanna; Brendan C Dickson; Peter C Ferguson
Journal:  Clin Orthop Relat Res       Date:  2010-10-19       Impact factor: 4.176

8.  Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.

Authors:  Kate Witkowska; Kyla M Smith; Sylvia Y M Yao; Amy M L Ng; Debbie O'Neill; Edward Karpinski; James D Young; Christopher I Cheeseman
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

9.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

10.  ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding pocket.

Authors:  Tomoka Gose; Talha Shafi; Yu Fukuda; Sourav Das; Yao Wang; Alice Allcock; Ailsa Gavan McHarg; John Lynch; Taosheng Chen; Ikumi Tamai; Anang Shelat; Robert C Ford; John D Schuetz
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.